Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of

M A Pfaller1, S A Messer, L Boyken

  • 1Department of Pathology, Roy J and Lucille A Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA. michael-pfaller@uiowa.edu

Insights

The fluconazole disk diffusion method is a useful approach for determining Cryptococcus neoformans susceptibility. This method showed good agreement with broth microdilution, making it a viable alternative for clinical laboratories.

Area of Science:

  • Medical Mycology
  • Antimicrobial Susceptibility Testing

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen.
  • Fluconazole is a key antifungal agent for treating cryptococcosis.
  • Accurate susceptibility testing is crucial for effective treatment.

Purpose of the Study:

  • To evaluate the NCCLS M44-P fluconazole disk diffusion method.
  • To compare disk diffusion with the NCCLS M27-A2 broth microdilution method.
  • To assess the utility of disk diffusion for C. neoformans susceptibility testing.

Main Methods:

  • Disk diffusion testing on Mueller-Hinton agar with glucose and methylene blue.
  • Broth microdilution testing according to NCCLS M27-A2 guidelines.
  • Analysis of 276 C. neoformans isolates.

Main Results:

  • Overall categorical agreement between methods was 86%.
  • Disk diffusion showed 0% very major errors and 2% major errors.
  • 93.8% of isolates were susceptible to fluconazole by broth microdilution.

Conclusions:

  • The disk diffusion method is a potentially useful tool for C. neoformans fluconazole susceptibility.
  • The modified disk diffusion method demonstrates good agreement with established methods.
  • This offers a practical alternative for clinical settings.